BACKGROUND:The roles of transforming growth factor (TGF)-β1, fibroblast growth factor basic (FGF-b) and interleukin (IL)-6 released from human coronavirus (HCoV)-229 E-infected human nasal epithelial (HNE) cells and 2009 pandemic influenza virus-infected type II human alveolar epithelial (A549) cells in fibroblast proliferation were studied to elucidate the early mechanisms of airway and lung remodeling initiated by viral infection through epithelial-derived activation of fibroblasts. METHODS:The number of human fetal lung fibroblasts (MRC-5) cocultured with virus-infected HNE cells or A549 cells, which were cultured using air-interface methods, and the levels of growth factors in supernatants were measured. RESULTS:The number of MRC-5 cells cocultured with virus-infected HNE cells or A549 cells was greater than that of MRC-5 cells cocultured with uninfected cells. Treatment of MRC-5 cells and cocultured virus-infected HNE or A549 cells with an anti-TGF-β1 antibody and an anti-FGF-b antibody reduced the number of MRC-5 cells. The levels of TGF-β1 and FGF-b in the supernatants of MRC-5 cells cocultured with virus-infected epithelial cells were greater than those in the supernatants of MRC-5 cells cocultured with uninfected cells. Addition of an anti-TGF-β1 antibody reduced FGF-b levels after viral infection. IL-6 levels were increased in HCoV-229 E-infected HNE cells, and treatment with an anti-IL-6 antibody reduced the number of MRC-5 cells cocultured with HCoV-229 E-infected HNE cells. Administration of the p38 MAPK phosphorylation inhibitor SB203580 reduced the number of MRC-5 cells. CONCLUSIONS:HNE cells and A549 cells may release TGF-β1, FGF-b and IL-6, which increase fibroblast proliferation after viral infection partly via MAPK activation.
The champagne bottle neck sign (CBNS) is regarded as a characteristic finding of the cervical internal carotid artery in patients with moyamoya disease (MMD). However, there is no universal definition, and its clinical significance remains unclear. Here, we aimed to propose a novel CBNS grading system using catheter angiography. First, we proposed a novel grading system for CBNS using the lateral view of common carotid artery angiograms. Three grades were defined (grades 0,1, and 2). CBNS grade was defined as a ratio of the internal carotid artery diameter to the common carotid artery diameter of < 0.5 on the lateral view of the common carotid artery angiogram. CBNS grade 2 additionally required plump enlargement of the bulbous portion of the cervical internal carotid artery. We then conducted a retrospective case-control study including 134 patients (247 sides) with MMD and 94 patients (98 sides) with non-MMD intracranial large artery stenosis/occlusion. Finally, we analyzed the association between CBNS grade and clinical features, including Suzuki stage and hemodynamic impairment. CBNS grade 2 demonstrated a strong association with MMD, although grade 2 CBNS was infrequently observed among patients with non-MMD intracranial large-artery stenosis/occlusion (p < 0.001). Additionally, multivariate analysis demonstrated a significant association between CBNS grade 2 and hemodynamic impairment, which was present in 32.5
Purpose: User-derived electrometer calibration factors (k(elec, user)) have been proposed as a practical approach for electrometer quality assurance in radiotherapy dosimetry. However, the contribution of long-term stability to the uncertainty of k(elec, user) has not been quantitatively evaluated. This study aimed to assess the long-term stability of k(elec, user) over a 28-month period and to validate the method using different signal input techniques. Methods: A RAMTEC Solo electrometer was used as the reference electrometer, and three electrometers (UNIDOSwebline, RAMTEC Duo, and Super MAX) were evaluated as electrometers under test. Electrometer sensitivity ratios were measured using three signal input methods: A LINAC-based method, a battery-powered current source (SCG002), and a servo-controlled current source (EMF521R). User-derived calibration factors were calculated from the sensitivity ratios and the calibration coefficient of the reference electrometer. Long-term stability was evaluated from repeated measurements over 28 months using linear regression analysis, and the associated uncertainty component was estimated according to the Guide to the Expression of Uncertainty in Measurement (GUM). Results: The coefficients of variation for repeated measurements were <= 0.071% for all methods. The k(elec, user) values obtained using the LINAC method, SCG002, and EMF521R agreed within 0.1%, with a maximum relative difference of 0.06%. Over the 28-month observation period, the largest estimated drift was 1.84 & times; 10(-)(4), corresponding to a Type B standard uncertainty of 1.06 & times; 10(-)(4) (1.06 & times; 10(-)(2)%). The combined standard uncertainty of k(elec, user) remained 0.20%, and the experimentally determined long-term stability component had a negligible effect on the overall uncertainty. Conclusions: The influence of signal input method on k(elec, user) was minimal, and consistent results were obtained using LINAC-based and current-source-based measurements. The uncertainty contribution from long-term stability over 28 months was negligible compared with the reported uncertainty of electrometer calibration factors. These findings support the use of periodic in-house sensitivity comparison measurements as a complementary quality assurance tool for monitoring electrometer performance between external calibrations. These findings extend previous studies by providing quantitative evidence of the relative sensitivity stability of user-derived electrometer calibration factors and thereby support their application for routine in-house quality assurance.
Background Sepsis-associated acute kidney injury (SA-AKI) contributes to a large morbidity and mortality burden. While emerging evidence suggests that the trajectory of SA-AKI, such as persistent SA-AKI, is associated with clinical outcomes, their association in septic shock remains unclear. Methods In this multicenter prospective study in 20 ICUs, we investigated the incidence, clinical impact, and risk factors of persistent SA-AK in patients with septic shock requiring high-dose norepinephrine. Persistent SA-AKI was defined as an episode of AKI by KDIGO criteria lasting for at least 48 h in sepsis defined by sepsis-3 criteria. We assessed the association of persistent SA-AKI with clinical outcomes using multivariable Cox proportional hazards and logistic regression models. We also investigated risk factors for persistent SA-AKI. Results In 257 patients with septic shock, 215 (84%) developed SA-AKI within 48 h of ICU admission, and 111 (43%) progressed to persistent SA-AKI. Patients with persistent SA-AKI had a significantly higher risk of 90-day mortality (adjusted HR, 2.75; 95% CI, 1.39–5.42; P = 0.004) and hospital mortality (adjusted OR, 4.29; 95% CI, 1.87–10.70; P < 0.001) than those with transient SA-AKI. Greater time-weighted average vasoactive-inotropic score was independently associated with the development of persistent SA-AKI (adjusted OR, 1.03; 95% CI, 1.01–1.06; P = 0.03). Conclusions In patients with septic shock requiring high-dose norepinephrine, persistent SA-AKI is associated with worse clinical outcomes. These findings support the need for further research on risk stratification and targeted interventions based on the trajectory of SA-AKI. Trial registration The study was registered on UMIN Clinical Trial Registry (UMIN000038302) on November 1, 2019.
[This corrects the article DOI: 10.1016/j.aicoj.2026.100041.].